Innovative Biotech Therapies in the Middle East - Advances
in Biologics, Cell, and Gene Therapy (CGT)
This comprehensive program discusses the transformative potential of innovative biotech therapies—including biologics, cell therapies, and gene therapies—with a special focus on the Middle Eastern context. It examines the scientific principles, mechanisms, and applications of these therapies, highlighting specific examples of such therapies by name, while addressing the challenges of integrating such advanced modalities into healthcare systems. By incorporating detailed case studies of Qatar and Bahrain, the program underscores the importance of localized adaptations, regulatory evolution, and strategic investments in fostering the adoption of precision medicine. With an emphasis on leveraging regional initiatives, collaborative research, and real-world evidence, the program aims to guide policymakers, researchers, and healthcare professionals in advancing patient care and innovation across the region.
Enrollment fee for full access is AED 775 ($210 USD)
Enrollment fee for full access is AED 775 ($210 USD)
Write your awesome label here.
Write your awesome label here.
— Overview of course offerings
We provide high-quality, evidence-based expert courses
Our training provides you with the knowledge and skills you need to confidently understand and use course content.